All recalls
Every recall from CPSC, FDA, USDA and NHTSA, newest first. Each one links to the agency's official notice. Looking for one product? Check a product.
2,237 recalls ยท page 18 of 45
-
Class IIofficial
Safecor Health, LLC recalls Haloperidol Lactate InjectionLabeling: Not Elsewhere Classified:Incorrect RFID tag labels applied to product by repackaging firm.
-
Class IIIofficial
STAQ Pharma, Inc. recalls Hydromorphone HCL PFLabeling: Incorrect or Missing Lot and/or Exp Date
-
Class IIIofficial
STAQ Pharma, Inc. recalls Ketamine HydrochlorideLabeling: Incorrect or Missing Lot and/or Exp Date
-
Class IIIofficial
STAQ Pharma, Inc. recalls FentaNYL Citrate PFLabeling: Incorrect or Missing Lot and/or Exp Date
-
Class IIofficial
Amerisource Health Services LLC recalls Sucralfate TabletsCGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.
-
Class IIofficial
USV Private Limited recalls Olopatadine Hydrochloride Ophthalmic Solution USP 0.1 %Failed Impurities/Degradation Specifications: The result for 'Any individual unspecified impurity' exceeds the specification limit.
-
Class IIofficial
ibspot recalls Taoscare Motion Sickness Patches 36-count boxMarketed Without an Approved NDA/ANDA
-
Class IIofficial
Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release CapsulesCGMP Deviations: N-nitroso-duloxetine impurity above the safety assessment limit of 12.5ppm.
-
Class IIofficial
Astrazeneca Pharmaceuticals recalls Fasenra (benralizumab) InjectionLack of Assurance of Sterility:
-
Class Iofficial
Mohamed Hagar recalls Mojo Max Fusion XXXMarketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).
-
Class IIofficial
Rising Pharma Holding, Inc. recalls CarbidopaProduct mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength Carbidopa, Levodopa, and Entacapone film-coated tablets (25 mg/100 mg/200 mg).
-
Class IIofficial
Teva Pharmaceuticals USA, Inc recalls Prazosin HydrochlorideCGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots.
-
Class IIofficial
Teva Pharmaceuticals USA, Inc recalls Prazosin HydrochlorideCGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots.
-
Class IIofficial
Teva Pharmaceuticals USA, Inc recalls Prazosin HydrochlorideCGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots.
-
Class IIofficial
Viona Pharmaceuticals Inc recalls Tavaborole Topical solution 5%Discoloration
-
Class IIofficial
Heritage Pharmaceuticals Inc recalls Desipramine Hydrochloride TabletsCGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
-
Class IIofficial
Heritage Pharmaceuticals Inc recalls Desipramine Hydrochloride TabletsCGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
-
Class IIofficial
Heritage Pharmaceuticals Inc recalls Desipramine Hydrochloride TabletsCGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
-
Class IIofficial
Heritage Pharmaceuticals Inc recalls Desipramine Hydrochloride TabletsCGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
-
Class IIofficial
Heritage Pharmaceuticals Inc recalls Desipramine Hydrochloride TabletsCGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
-
Class IIofficial
Heritage Pharmaceuticals Inc recalls Desipramine Hydrochloride TabletsCGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
-
Class IIofficial
Advanced Pharmaceutical Technology, Inc. recalls TESTO-100 CIII (testosterone 100 mg)Lack of Assurance of Sterility: Potential microbial contamination of subcutaneous pellets.
-
Class IIofficial
Aspiro Pharma Limited recalls Ketorolac Tromethamine InjectionPresence of Particulate Matter: Particulate matter identified as glass
-
Class IIofficial
Church & Dwight Co., Inc. recalls ZICAM" MEDICATED FRUIT DROPS ELDERBERRY FLAVORLabeling: Label Mix-up: The product in the bottle contains elderberry and the label failed to indicate the inclusion of elderberry as an ingredient.
-
Class IIofficial
Acuity Specialty Products, Inc. recalls WyandottecGMP deviations: The recall was initiated because required receipt testing of incoming alcohol components used to manufacture the listed hand sanitizers was not performed, so methanol risk could not be excluded.
-
Class IIofficial
Acuity Specialty Products, Inc. recalls AFCOcGMP deviations: The recall was initiated because required receipt testing of incoming alcohol components used to manufacture the listed hand sanitizers was not performed, so methanol risk could not be excluded.
-
Class IIofficial
Acella Pharmaceuticals, LLC recalls Doxycycline Hyclate TabletsFailed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications.
-
Class IIofficial
Medline Industries, LP recalls MedlineSubpotent Drug
-
Class IIofficial
Dr. Reddy's Laboratories, Inc. recalls Succinylcholine Chloride InjectionOut-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.
-
Class IIofficial
SV Labs Prescott Corporation recalls Aloe Up Sport Performance Sunscreen Lotion SPF 30cGMP deviations: the firm released and distributed product which failed total aerobic microbial count testing.
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Entecavir TabletsFailed impurity/degradation specifications:Out of Specification result for an individual organic impurity
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Entecavir TabletsFailed impurity/degradation specifications:Out of Specification result for an individual organic impurity
-
Class IIofficial
Acme United Corporation recalls Sting Relief SwabsProduct Mix-up
-
Class IIofficial
Park Avenue Compounding recalls Fentanyl citrateCGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.
-
Class IIofficial
RC Outsourcing, LLC recalls Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringeLack of assurance of sterility.
-
Class IIofficial
Ascend Laboratories, LLC recalls Atorvastatin Calcium Tablets USPFailed Dissolution Specifications
-
Class IIofficial
Ascend Laboratories, LLC recalls Atorvastatin Calcium Tablets USPFailed Dissolution Specifications
-
Class IIofficial
Ascend Laboratories, LLC recalls Atorvastatin Calcium Tablets USPFailed Dissolution Specifications
-
Class IIofficial
Ascend Laboratories, LLC recalls Atorvastatin Calcium Tablets USPFailed Dissolution Specifications
-
Class IIofficial
Park Avenue Compounding recalls Phenylephrine HCICGMP Deviations
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Azelaic Acid GelCGMP Deviations: Market complaints received for gritty texture (grainy)
-
Class IIofficial
Accord Healthcare, Inc. recalls Levothyroxine Sodium TabletsSubpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.
-
Class Iofficial
IntegraDose Compounding Services LLC recalls Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous useSubpotent Drug: Testing revealed there was no oxytocin in the IV bag.
-
Class IIofficial
Graviti Pharmaceuticals Private Limited recalls Bupropion Hydrochloride Extended-Release Tablets USP (XL)Failed Tablet/Capsule Specifications
-
Class IIofficial
Amerisource Health Services LLC recalls Carbamazepine Extended-Release TabletsFailed Dissolution Specifications.
-
Class IIofficial
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Major ChlorproMAZINE Hydrochloride TabletsCGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit
-
Class IIofficial
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Major ChlorproMAZINE Hydrochloride TabletsCGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit
-
Class IIofficial
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Major ChlorproMAZINE Hydrochloride TabletsCGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit
-
Class IIofficial
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Major ChlorproMAZINE Hydrochloride TabletsCGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit
-
Class IIofficial
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Major ChlorproMAZINE Hydrochloride TabletsCGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit